Reveri is a technology company.
Reveri has raised $4.0M across 1 funding round.
Reveri has raised $4.0M in total across 1 funding round.
Reveri has raised $4.0M in total across 1 funding round.
Reveri's investors include Arkitekt Ventures, Background Capital, bloom venture partners, Broadway Angels, Merline Saintil, General Catalyst, Human Augmentation Syndicate, InReach Ventures, LifeX Ventures, Max Ventures, Operator Collective, The General Partnership.
Reveri is a health technology company developing an AI-powered mobile app for self-hypnosis and guided hypnotherapy. It serves individuals seeking non-medication solutions for mental and physical well-being, addressing problems like chronic pain, stress, anxiety, poor sleep, lack of focus, nicotine addiction, and unwanted habits.[1][2][3][4] The app delivers personalized sessions in as little as 10 minutes, backed by over 45 years of clinical research, with reported improvements after just one use and over 1 million users.[3][4] Founded in 2019 (with co-founding noted in 2020), Reveri has raised $1.8M in seed VC funding and operates from San Francisco (with a Stinson Beach PO Box), positioning it in the growing digital health and mental health tech markets.[1][2]
Reveri was founded by Stanford psychiatrist Dr. David Spiegel, a pioneer in clinical hypnosis with over 45 years of experience treating more than 7,000 patients since 1967, and entrepreneur Ariel Poler, whose background includes scaling companies like Strava and StumbleUpon.[2][3][4] Spiegel, Associate Chair of Psychiatry at Stanford School of Medicine and author of over 400 research papers on hypnotherapy, sought to democratize hypnosis after seeing its transformative effects on diverse patient needs—relieving pain, changing behaviors, and enhancing mind-body connections without side effects.[3][4] The idea emerged from combining Spiegel's academic expertise (Stanford, Harvard) with Poler's business acumen, leveraging mobile tech to scale access; early traction includes launching specialized content like Quit Vaping sessions amid rising nicotine epidemics.[2][3]
Reveri rides the digital health and mental health tech boom, where demand for accessible, non-pharmacological wellness tools surges amid rising anxiety, chronic pain, sleep disorders, and addiction crises—exacerbated by post-pandemic stress and vaping epidemics affecting 55 million globally.[1][2][3] Timing aligns with AI advancements enabling personalized behavioral interventions at scale, fitting into expert collections like CB Insights' Digital Health (10,846 companies) and Mental Health Tech (742 companies), excluding pharma or hardware.[1] Market forces favor it: growing consumer adoption of apps (over 1M users), clinician-validated hypnosis, and AI's role in health data personalization, positioning Reveri to influence the ecosystem by mainstreaming hypnotherapy as a scalable alternative to therapy or meds.[1][3][4]
Reveri is poised to expand its AI-driven personalization, potentially integrating more multimodal data (e.g., wearables) for deeper habit transformation and partnerships in healthcare. Trends like AI in behavioral health, rising wellness spending, and demand for addiction/mental health solutions will propel growth, especially as clinical hypnosis gains validation. Its influence may evolve from niche app to ecosystem leader, empowering millions in mind-body wellness—echoing its founding mission to deliver immediate, side-effect-free relief at scale.[3][4]
Reveri has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Seed in February 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Feb 1, 2022 | $4.0M Seed | Arkitekt Ventures, Background Capital, bloom venture partners, Broadway Angels, Merline Saintil, General Catalyst, Human Augmentation Syndicate, InReach Ventures, LifeX Ventures, Max Ventures, Operator Collective, The General Partnership, Trust Ventures, Aston Motes, Bobby Lo, Mantas Mikuckas, Nick Caldwell |